ticlopidine has been researched along with Bone Loss, Osteoclastic in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Twenty-week-old mice (n = 10-12) were ovariectomized or sham treated and dosed orally with clopidogrel (1 mg/kg) or vehicle (NaCl) daily for 4 weeks." | 1.38 | Clopidogrel (Plavix), a P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo. ( Arnett, TR; Brandao-Burch, A; Hajjawi, M; Jorgensen, NR; Orriss, IR; Patel, JJ; Schwarz, P; Syberg, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Syberg, S | 1 |
| Brandao-Burch, A | 1 |
| Patel, JJ | 1 |
| Hajjawi, M | 1 |
| Arnett, TR | 1 |
| Schwarz, P | 1 |
| Jorgensen, NR | 1 |
| Orriss, IR | 1 |
| Su, X | 1 |
| Floyd, DH | 1 |
| Hughes, A | 1 |
| Xiang, J | 1 |
| Schneider, JG | 1 |
| Uluckan, O | 1 |
| Heller, E | 1 |
| Deng, H | 1 |
| Zou, W | 1 |
| Craft, CS | 1 |
| Wu, K | 1 |
| Hirbe, AC | 1 |
| Grabowska, D | 1 |
| Eagleton, MC | 1 |
| Townsley, S | 1 |
| Collins, L | 1 |
| Piwnica-Worms, D | 1 |
| Steinberg, TH | 1 |
| Novack, DV | 1 |
| Conley, PB | 1 |
| Hurchla, MA | 1 |
| Rogers, M | 1 |
| Weilbaecher, KN | 1 |
2 other studies available for ticlopidine and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Clopidogrel (Plavix), a P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo.
Topics: Alkaline Phosphatase; Animals; Azo Compounds; Biomarkers; Bone and Bones; Bone Density; Bone Resorpt | 2012 |
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling.
Topics: Adenosine Diphosphate; Animals; Arthritis, Experimental; Bone Neoplasms; Bone Remodeling; Bone Resor | 2012 |